<DOC>
	<DOCNO>NCT02768441</DOCNO>
	<brief_summary>The pharmacokinetics 10 12 individual receive 60 mg sustain release dexamphetamine study . These individual receive medication previous trial pharmacodynamics investigate . This trial last 5 consecutive day blood sample draw pharmacokinetics analysis . Dried blood spot also collect clinical validation bioanalytical method wherein use .</brief_summary>
	<brief_title>Dexamphetamine Sustained Release Pharmacokinetics Clinical Validation Dried Blood Spots</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<criteria>Have complete least 80 % previous study ( CATCH ) Be able willing participate study assessment Have provide write informed consent . Any intake dexamphetamine 7 day less start propose study ; Contraindications dexamphetamine ( desire ) pregnancy continue lactation Insufficient command Dutch language Current participation another trial</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>